Cargando…
The Imaging of Insulinomas Using a Radionuclide-Labelled Molecule of the GLP-1 Analogue Liraglutide: A New Application of Liraglutide
OBJECTIVE: This study explores a new, non-invasive imaging method for the specific diagnosis of insulinoma by providing an initial investigation of the use of (125)I-labelled molecules of the glucagon-like peptide-1 (GLP-1) analogue liraglutide for in vivo and in vitro small-animal SPECT/CT (single-...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013070/ https://www.ncbi.nlm.nih.gov/pubmed/24805918 http://dx.doi.org/10.1371/journal.pone.0096833 |
_version_ | 1782315007461031936 |
---|---|
author | Lv, Jing Pan, Yu Li, Xiao Cheng, Dengfeng Liu, Shuai Shi, Hongcheng Zhang, Yifan |
author_facet | Lv, Jing Pan, Yu Li, Xiao Cheng, Dengfeng Liu, Shuai Shi, Hongcheng Zhang, Yifan |
author_sort | Lv, Jing |
collection | PubMed |
description | OBJECTIVE: This study explores a new, non-invasive imaging method for the specific diagnosis of insulinoma by providing an initial investigation of the use of (125)I-labelled molecules of the glucagon-like peptide-1 (GLP-1) analogue liraglutide for in vivo and in vitro small-animal SPECT/CT (single-photon emission computed tomography/computed tomography) imaging of insulinomas. METHODS: Liraglutide was labelled with (125)I by the Iodogen method. The labelled (125)I-liraglutide compound and insulinoma cells from the INS-1 cell line were then used for in vitro saturation and competitive binding experiments. In addition, in a nude mouse model, the use of (125)I-liraglutide for the in vivo small-animal SPECT/CT imaging of insulinomas and the resulting distribution of radioactivity across various organs were examined. RESULTS: The labelling of liraglutide with (125)I was successful, yielding a labelling rate of approximately 95% and a radiochemical purity of greater than 95%. For the binding between (125)I-liraglutide and the GLP-1 receptor on the surface of INS-1 cells, the equilibrium dissociation constant (K(d)) was 128.8±30.4 nmol/L(N = 3), and the half-inhibition concentration (IC(50)) was 542.4±187.5 nmol/L(N = 3). Small-animal SPECT/CT imaging with (125)I-liraglutide indicated that the tumour imaging was clearest at 90 min after the (125)I-liraglutide treatment. An examination of the in vivo distribution of radioactivity revealed that at 90 min after the (125)I-liraglutide treatment, the target/non-target (T/NT) ratio for tumour and muscle tissue was 4.83±1.30(N = 3). Our study suggested that (125)I-liraglutide was predominantly metabolised and cleared by the liver and kidneys. CONCLUSION: The radionuclide (125)I-liraglutide can be utilised for the specific imaging of insulinomas, representing a new non-invasive approach for the in vivo diagnosis of insulinomas. |
format | Online Article Text |
id | pubmed-4013070 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-40130702014-05-09 The Imaging of Insulinomas Using a Radionuclide-Labelled Molecule of the GLP-1 Analogue Liraglutide: A New Application of Liraglutide Lv, Jing Pan, Yu Li, Xiao Cheng, Dengfeng Liu, Shuai Shi, Hongcheng Zhang, Yifan PLoS One Research Article OBJECTIVE: This study explores a new, non-invasive imaging method for the specific diagnosis of insulinoma by providing an initial investigation of the use of (125)I-labelled molecules of the glucagon-like peptide-1 (GLP-1) analogue liraglutide for in vivo and in vitro small-animal SPECT/CT (single-photon emission computed tomography/computed tomography) imaging of insulinomas. METHODS: Liraglutide was labelled with (125)I by the Iodogen method. The labelled (125)I-liraglutide compound and insulinoma cells from the INS-1 cell line were then used for in vitro saturation and competitive binding experiments. In addition, in a nude mouse model, the use of (125)I-liraglutide for the in vivo small-animal SPECT/CT imaging of insulinomas and the resulting distribution of radioactivity across various organs were examined. RESULTS: The labelling of liraglutide with (125)I was successful, yielding a labelling rate of approximately 95% and a radiochemical purity of greater than 95%. For the binding between (125)I-liraglutide and the GLP-1 receptor on the surface of INS-1 cells, the equilibrium dissociation constant (K(d)) was 128.8±30.4 nmol/L(N = 3), and the half-inhibition concentration (IC(50)) was 542.4±187.5 nmol/L(N = 3). Small-animal SPECT/CT imaging with (125)I-liraglutide indicated that the tumour imaging was clearest at 90 min after the (125)I-liraglutide treatment. An examination of the in vivo distribution of radioactivity revealed that at 90 min after the (125)I-liraglutide treatment, the target/non-target (T/NT) ratio for tumour and muscle tissue was 4.83±1.30(N = 3). Our study suggested that (125)I-liraglutide was predominantly metabolised and cleared by the liver and kidneys. CONCLUSION: The radionuclide (125)I-liraglutide can be utilised for the specific imaging of insulinomas, representing a new non-invasive approach for the in vivo diagnosis of insulinomas. Public Library of Science 2014-05-07 /pmc/articles/PMC4013070/ /pubmed/24805918 http://dx.doi.org/10.1371/journal.pone.0096833 Text en © 2014 Lv et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Lv, Jing Pan, Yu Li, Xiao Cheng, Dengfeng Liu, Shuai Shi, Hongcheng Zhang, Yifan The Imaging of Insulinomas Using a Radionuclide-Labelled Molecule of the GLP-1 Analogue Liraglutide: A New Application of Liraglutide |
title | The Imaging of Insulinomas Using a Radionuclide-Labelled Molecule of the GLP-1 Analogue Liraglutide: A New Application of Liraglutide |
title_full | The Imaging of Insulinomas Using a Radionuclide-Labelled Molecule of the GLP-1 Analogue Liraglutide: A New Application of Liraglutide |
title_fullStr | The Imaging of Insulinomas Using a Radionuclide-Labelled Molecule of the GLP-1 Analogue Liraglutide: A New Application of Liraglutide |
title_full_unstemmed | The Imaging of Insulinomas Using a Radionuclide-Labelled Molecule of the GLP-1 Analogue Liraglutide: A New Application of Liraglutide |
title_short | The Imaging of Insulinomas Using a Radionuclide-Labelled Molecule of the GLP-1 Analogue Liraglutide: A New Application of Liraglutide |
title_sort | imaging of insulinomas using a radionuclide-labelled molecule of the glp-1 analogue liraglutide: a new application of liraglutide |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013070/ https://www.ncbi.nlm.nih.gov/pubmed/24805918 http://dx.doi.org/10.1371/journal.pone.0096833 |
work_keys_str_mv | AT lvjing theimagingofinsulinomasusingaradionuclidelabelledmoleculeoftheglp1analogueliraglutideanewapplicationofliraglutide AT panyu theimagingofinsulinomasusingaradionuclidelabelledmoleculeoftheglp1analogueliraglutideanewapplicationofliraglutide AT lixiao theimagingofinsulinomasusingaradionuclidelabelledmoleculeoftheglp1analogueliraglutideanewapplicationofliraglutide AT chengdengfeng theimagingofinsulinomasusingaradionuclidelabelledmoleculeoftheglp1analogueliraglutideanewapplicationofliraglutide AT liushuai theimagingofinsulinomasusingaradionuclidelabelledmoleculeoftheglp1analogueliraglutideanewapplicationofliraglutide AT shihongcheng theimagingofinsulinomasusingaradionuclidelabelledmoleculeoftheglp1analogueliraglutideanewapplicationofliraglutide AT zhangyifan theimagingofinsulinomasusingaradionuclidelabelledmoleculeoftheglp1analogueliraglutideanewapplicationofliraglutide AT lvjing imagingofinsulinomasusingaradionuclidelabelledmoleculeoftheglp1analogueliraglutideanewapplicationofliraglutide AT panyu imagingofinsulinomasusingaradionuclidelabelledmoleculeoftheglp1analogueliraglutideanewapplicationofliraglutide AT lixiao imagingofinsulinomasusingaradionuclidelabelledmoleculeoftheglp1analogueliraglutideanewapplicationofliraglutide AT chengdengfeng imagingofinsulinomasusingaradionuclidelabelledmoleculeoftheglp1analogueliraglutideanewapplicationofliraglutide AT liushuai imagingofinsulinomasusingaradionuclidelabelledmoleculeoftheglp1analogueliraglutideanewapplicationofliraglutide AT shihongcheng imagingofinsulinomasusingaradionuclidelabelledmoleculeoftheglp1analogueliraglutideanewapplicationofliraglutide AT zhangyifan imagingofinsulinomasusingaradionuclidelabelledmoleculeoftheglp1analogueliraglutideanewapplicationofliraglutide |